Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More
Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More
Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More
Submitted by
admin
on January 7, 2014 - 11:47am
Source:
24/7 Wall St
News Tags:
Celldex Therapeutics
Immunomedics
Keryx
Merrimack Pharmaceuticals
Protalix BioTherapeutics
Headline:
Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More
Do Not Allow Advertisers to Use My Personal information
